Due to the involvement of p38 MAPKs in cell transformation processes, such as unlimited proliferation, protection against apoptotic cell death, angiogenesis, tissue invasion, and metastasis, p38 isoforms emerged as drug targets for cancer therapy [2,12,13]. The gene discussed is MAPK14; the disease is cancer.